Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
48
ATNM Quote, Financials, Valuation and Earnings
Last price:
$1.19
Seasonality move
:
5.17%
Day range:
$1.23 - $1.30
52-week range:
$1.03 - $10.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.06x
Volume:
187.7K
Avg. volume:
159.3K
1-year change:
-80.74%
Market cap:
$40.6M
Revenue:
$81K
EPS (TTM):
-$1.39
Actinium Pharmaceuticals Number of Institutional Trades
Actinium Pharmaceuticals Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$31.1M
(Last 6 Months)
Current Institutional Ownership Percentage
44.47%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$21.1M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Actinium Pharmaceuticals Institutional Ownership
-
What Percentage Of ATNM Is Owned by Institutions?
44.47% of ATNM is owned by institutions.
-
How Many Institutions Own ATNM Shares?
Actinium Pharmaceuticals stock is owned by 176 institutional shareholders at this time.
-
Have Institutions Been Buying ATNM Stock?
Yes, institutions have bought 11.5M shares of ATNM in the last quarter.
-
Have Institutions Been Selling ATNM Stock?
Yes, institutions have sold 9M shares of ATNM over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
